The researchers also observed that 532 participants with BMI 35 at week 0, who had tolerated their assigned dose of medication, were then escalated to the maximum tolerated dose (9mg or 12mg) for a further 24 weeks
Pharmacological treatment typically begins with non-insulin antihyperglycemic agents, either as monotherapy or in combination
When it comes to qualifying for semaglutide GLP-1 injections for weight loss, patient suitability will be determined in cooperation with the experts at Abundant Life Healthcare
Psychotherapy and Psychosomatics , 84(5), 254258
Over more than a decade in clinical practice, he saw how excess weight and metabolic dysfunction can affect physical function, recovery, mobility, energy, and long-term disease risk
A 2024 phase 2 RCT documented 2.6% hip and 2.1% lumbar spine bone density reductions within 52 weeks at the 1.0 mg semaglutide dose in a specific study population